Simone D'adamio

Reggio Nell'emilia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Real Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience.

Real Life Comparative Effectiveness of IL-23 Inhibitors in the Treatment of Moderate to Severe Psoriasis: A Multicenter Experience.

Journal: Dermatology practical & conceptual

Published: March 25, 2024

Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience.

Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience.

Journal: Expert opinion on biological therapy

Published: April 07, 2022

Use of Apremilast® in the psoriasis treatment: a real-life multicenter Italian experience.

Use of Apremilast® in the psoriasis treatment: a real-life multicenter Italian experience.

Journal: Italian journal of dermatology and venereology

Published: September 21, 2021

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis.

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis.

Journal: Expert opinion on biological therapy

Published: December 28, 2019

Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.

Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.

Journal: Dermatologic therapy

Published: March 20, 2019

Successful treatment of psoriatic crumbly nails with ustekinumab.

Successful treatment of psoriatic crumbly nails with ustekinumab.

Journal: Dermatologic therapy

Published: November 19, 2018

Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy.

Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy.

Journal: Molecular diagnosis & therapy

Published: August 05, 2018

Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation.

Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation.

Journal: Expert opinion on biological therapy

Published: May 26, 2018

Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab.

Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab.

Journal: The Journal of dermatological treatment

Published: April 21, 2018

Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients.

Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients.

Journal: Expert opinion on biological therapy

Published: December 19, 2017

The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.

The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.

Journal: Molecular diagnosis & therapy

Published: April 05, 2017

Tildrakizumab for treating psoriasis.

Tildrakizumab for treating psoriasis.

Journal: Expert opinion on biological therapy

Published: March 09, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026